PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC
Visit https://www.peervoice.com/CCG860 to view the entire programme with slides. After completing “Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC”, participants will be able to: Identify new targets for antibody-drug conjugates and their prevalence and role in patients with NSCLC; Use recommended strategies for detecting expression of novel antigenic targets by tumour cells in patients with NSCLC; and Determine the potential impact of antibody-drug conjugates with novel antigenic targets on later-line treatment strategies in patients with NSCLC.